Business and People Update - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Business and People Update Industry news focusing on the people and organizations who work in the clinical trials profession

Source: Applied Clinical Trials


Jon Green
People


Tammy Miller
•As a board of director for ERBI (Cambridge, UK) for many years, the current vice president of business operations for MedImmune (Gaithersburg, MD), Jon Green, will become the new Chairman for the organization.

•Now the new vice president of project management for ERT (Philadelphia, PA), Tammy Miller will hold the responsibility of globally implementing and delivering the company's project assurance methodology, which will include developing and executing strategic plans to enhance customer service.


Don Berg


Gerald Finken
•With the promotion of Don Berg to president of Clinical Supplies Management (Fargo, ND), who will now manage operations, sales, and finance divisions of the company, the role of chief executive officer has been given to Gerald Finken, who will now focus on business strategies and growth opportunities, including development of on-demand packaging and labeling.

•Appointed to the position of CRF's (Lansdale, PA) clinical advisor, Nadina Jose, MD, will gain the responsibility of providing clinical insight and site experience to clients and internal staff, as well as provide therapeutic training, industry white paper leadership, speak at industry conferences, and represent the company's special interest groups.

BASi (West Lafayette, IN) has expanded its business development team in the United States with Don Hawker now representing the company in Canada and the Western United States, including California, Oregon, Washington, Idaho, Nevada, Utah, Montana, Arizona, and Wyoming.


Professor So Iwata, an Imperial College London scientist, accepting his 2 million Diamond Fellowship from the Biotechnology and Biological Sciences Research Council.
•The former founding executive, president, and chief scientific officer of Quintiles Laboratories (Westmont, IL), Frank Morrow, PhD, is now the chief operating officer of LabConnect (Seattle, WA).

Alliances

  • Having selected Medidata Solutions' (New York, NY) Medidata Rave EDC solution, Roche (Basel, Switzerland) will deploy its software as its core EDC system in a phased, multiyear approach across its five disease biology areas.
  • As a new collaboration to support Phase I cardiac safety clinical trials, Spaulding Clinical Research (West End, WI) has integrated Tiba Medical's (Portland, OR) Ambulo 2400 ambulatory blood pressure monitoring (ABPM) systems into its suite of offerings.
  • As an early adopter of Oracle's (Redwood Shores, CA) clinical data management platform, Premier Research (Philadelphia, PA) has recently implemented the company's enhanced EDC application, Oracle Remote Data Capture Onsite 4.5.3.
  • QPS (Newark, DE) has entered into an alliance with Taiwan's Development Center for Biotechnology (Xizhi City, Taiwan) to provide biopharmaceutical companies with comprehensive drug development services ranging from preclinical through clinical services.
  • Upon a three-year agreement signed with the FDA (Rockville, MD), GlobalSubmit (Philadelphia, PA) will enhance or upgrade its software products already in use at the agency as well as provide maintenance and support.
  • To cover such employment gaps as seasonal fluctuations, and maternity or holiday leave and to provide an additional resource option, Syngenta (Basel, Switzerland) has called upon SRG (Birmingham, UK) to implement a UK-wide temporary staff Recruitment Process Outsourcing solution.
  • Professor Bart de Strooper and his academic research group of Leuven, Belgium, and to-BBB (Leiden, The Netherlands) will now come together to combine their efforts in Alzheimer's research to develop a potential treatment for the disease.
  • An alliance with Biospective (Quebec, Canada) has allowed Perceptive Informatics (Boston, MA) to enhance its capabilities of processing and analyzing medical images for central nervous system and oncology trials.
  • To support the development of its pipeline of biologics for immune-related disorders, NovImmune (Geneva, Switzerland) has selected Medidata's (New York, NY) Trial Planning product suite, after already utilizing the company's Grants Manager and CRO Contractor.
  • To bring Colorado Prevention Center's (Denver, CO) training programs to a wider audience, Zipline Performance Group (Highland Ranch, CO) has entered into an agreement to manage its sales and marketing.

Awards

  • Oracle's (Redwood Shores, CA) Health Science Award for "Accelerating Interests for Better Health" was awarded to CTI (Cincinnati, OH) for their continuous collaboration with Oracle Health Sciences Global Business Unit.
  • An Imperial College London scientist, Professor So Iwata, has been awarded the first ever Diamond Professorial Fellowship from the Biotechnology and Biological Sciences Research Council, which is worth about 2 million.

Company News

  • The chairman of Almac Group (Craigavon, UK), Sir Allen McClay, has announced the establishment of the McClay Foundation, a charitable trust in Northern Ireland.
  • EPS (Tokyo, Japan) has become the first Asia-based contract research organization to reach the most advanced level of Medidata's (New York, NY) Aspire to Win program, Rave Accredited Plus.
  • Following its recent performance recruiting for the JUPITER trial, Synexus (Manchester, UK) has succeeded in the recruitment of 1221 patients across seven UK-based sites, and a total of 3273 patients were recruited worldwide across 87 sites for another global study.
  • Almac (Philadelphia, PA) has engaged in an aggressive hiring campaign in which it has hired 150 professionals in the past month, bringing its U.S. workforce to about 900, and is currently recruiting to fill 70 additional positions in the Philadelphia area.
  • To help ensure that the cancer center community can fulfill the new registration requirements for the U.S. National Cancer Institute (NCI) Clinical Trials Reporting Program, Velos (Fremont, CA) has provided new capabilities and functions in its eResearch platform.
  • Upon a successful UK MHRA Good Manufacturing Practices audit, Melbourn Scientific (Melbourn, UK) is expanding its facilities with the creation of a suite of rooms specific for early stage formulation development.

Mergers/ Acquisitions

  • Adding to ICON's (Dublin, Ireland) bioanalytical and immunoassay capabilities is the company's acquisition of Veeda laboratories, a provider of biomarker laboratory services.
  • The purchase of Covance's (Princeton, NJ) interactive voice and Web response services business for $10 million by Phase Forward (Waltham, MA) has also led to a multiyear marketing agreement mandating that Phase Forward market InForm EDC solution and Clarix interactive response technology solution to Covance clients.
  • Water Street Healthcare Partners (Chicago, IL) has acquired the pharmaceutical development division from AAIPharma (Wilmington, NC), renaming it AAIPharma Services Corp., and has also committed $75 million to expand the businesses' capabilities.

New Facilities

  • To support a growing American client base, Pharmaceutical Development Services (Nottingham, UK) has opened a U.S. office in River Hills, SC.
  • In acknowledgement of an increasing interest in outcomes research, CTI (Cincinnati, OH) has opened a new office in Raleigh, NC, to support biostatistics and outcomes research.
  • The customer care team of ERT (Philadelphia, PA) will move from their current location in Bridgewater, NJ, to the company's new headquarters located in Philadelphia, PA.
  • Remaining in Raleigh, NC, Trio Clinical Research (Raleigh, NC) has relocated its corporate headquarters to the Brier Creek Corporate Center, which will provide larger office space and more amenable facilities for staff and customers.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
7%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here